Menu
1 min read · estimated
APPROVED USE
What FDA approved
Adults and children age one or older with ALK-positive inflammatory myofibroblastic tumor that is unresectable, recurrent, or refractory.
LAMPGEN ANALYSIS
Why it matters
The ALK-selected indication expands targeted therapy to a rare mesenchymal tumor.
What research teams should watch
Verify histology and ALK testing and route pediatric patients to a center equipped for age-appropriate administration.
PRIMARY RECORDS